Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) EBITDA: 2009-2011

Historic EBITDA for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$114.1 million.

  • Lexicon Pharmaceuticals' EBITDA fell 48.68% to -$33.3 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$114.1 million, marking a year-over-year decrease of 19.20%. This contributed to the annual value of -$114.1 million for FY2011, which is 19.20% down from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its EBITDA stood at -$114.1 million for FY2011, which was down 19.20% from -$95.7 million recorded in FY2010.
  • In the past 5 years, Lexicon Pharmaceuticals' EBITDA ranged from a high of -$90.0 million in FY2009 and a low of -$114.1 million during FY2011.
  • For the 3-year period, Lexicon Pharmaceuticals' EBITDA averaged around -$99.9 million, with its median value being -$95.7 million (2010).
  • Data for Lexicon Pharmaceuticals' EBITDA shows a maximum YoY dropped of 19.20% (in 2011) over the last 5 years.
  • Over the past 3 years, Lexicon Pharmaceuticals' EBITDA (Yearly) stood at -$90.0 million in 2009, then declined by 6.41% to -$95.7 million in 2010, then dropped by 19.20% to -$114.1 million in 2011.